Long-term use of nonaspirin anti-inflammatory drugs (NSAIDs) is associated with an increased risk of renal cell cancer (RCC), according to a report in the September issue of Archives of Internal Medicine, one of the JAMA/Archives journals. According to background information in the article, in the United States, kidney cancer is the seventh leading type of […]
Scientists at the Fisher Center for Alzheimer’s Disease Research at The Rockefeller University, led by Paul Greengard, Ph.D., and Jennifer Warner-Schmidt, Ph.D., have shown that anti-inflammatory drugs, which include ibuprofen, aspirin, and naproxen, reduce the effectiveness of the most widely used class of antidepressant medications – the selective serotonin reuptake inhibitors, or SSRIs, taken for […]
The use of aspirin at least once per month is associated with a significant decrease in pancreatic cancer risk, according to results of a large case-control study presented at the AACR 102nd Annual Meeting 2011. Xiang-Lin Tan, Ph.D., M.D., a research fellow at Mayo Clinic in Rochester, Minn., said the findings from this large collaborative […]
Using aspirin for coronary heart prevention is less costly and more effective than doing nothing in men older than 45 with more than a 10 percent 10-year-risk of the disease, according to a study by researchers at RTI International, University of Michigan, and University of North Carolina at Chapel Hill. The results were published online […]
A study that appears in the current issue of Psychotherapy and Psychosomatics addresses the association between use of aspirin and statins and the risk of major depression. Chronic disease states characterized by inflammation are often accompanied by depression. Furthermore, depression is commonly reported among patients following exposure to cytokine-based immunotherapy, systemic inflammation has been implicated […]
Recent Comments